The largest database of trusted experimental protocols

Knockout sr xenofree cts ksr

Manufactured by Thermo Fisher Scientific

The KnockOut SR Xenofree CTS (KSR) is a serum-free, xeno-free medium designed for the culture and maintenance of human embryonic stem cells and induced pluripotent stem cells. It provides a defined, animal component-free environment to support the undifferentiated growth of these cell types.

Automatically generated - may contain errors

2 protocols using knockout sr xenofree cts ksr

1

Hepatic Induction of Induced Pluripotent Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hepatic induction of iPSCs was accomplished as described previously with minor modifications [39 –41 (link)]. In brief, single cells were generated after Accutase incubation (Sigma-Aldrich) for 6–8 minutes. Cells were resuspended in mTeSR-1 and transferred to Matrigel-precoated cell culture plates. After 24 hours, culture medium was changed for the next 3 days to DMEM/F12 supplemented with 100 ng/ml recombinant Activin-A (R&D Systems), 100 ng/ml fibroblast growth factor-2 (FGF2, Peprotech), 50 ng/ml recombinant human Wnt3a (R&D Systems). Concentration of KnockOut SR Xenofree CTS (KSR, Gibco) was 0%, 0.2% and 2.0% for the first, second and third day, respectively. For the next 8 days, cells were cultivated in DMEM/F12 supplemented with 10% KSR, 1mM NEAA, 1mM L-Glutamine, 1% dimethyl sulfoxide (DMSO, Sigma-Aldrich), and 100 ng/ml hepatocyte growth factor (HGF, Peprotech). Finally, cells were grown for 3 days in 10% KSR, 1mmol/L NEAA, 1mM L-Glutamine, and 0.1μM dexamethasone (Sigma-Aldrich).
+ Open protocol
+ Expand
2

Cholangiocyte Progenitor-like Cell Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cholangiocyte progenitor-like cell differentiation a protocol used before for hepatocyte-like cells was slightly modified18 (link). Briefly, iPSCs clusters instead of single cells were seeded to Matrigel-precoated wells in order to achieve an almost confluent cell layer at the next day. The medium was changed daily for the next three days to DMEM/F12 supplemented with 100 ng/ml recombinant Activin-A (R&D Systems), 100 ng/ml fibroblast growth factor-2 (FGF2, Peprotech), 50 ng/ml recombinant human Wnt3a (R&D Systems; day 1 and 2), 1 mM l-Glutamine (l-Glu, Sigma). KnockOut SR Xenofree CTS (KSR, Gibco) was added at 0.2% (day 2) and 2% (day 3). For the next 8 days (days 4–11), cells were cultivated in DMEM/F12 supplemented with 10% KSR, 1 mM NEAA, 1 mM L-Glu, 1% dimethyl sulfoxide (DMSO, Sigma), and 100 ng/ml hepatocyte growth factor (HGF, Peprotech). The maturation step, was prolonged up to day 15. 0.1 μM dexamethasone medium was added on day 12 to the medium (DMEM/F12, 10% KSR, 1 mM NEAA, 1 mM L-Glu, 1% DMSO) without any further medium changes at day 14 and day 15.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!